Clinical trials for Pulmonary embolism

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Pulmonary embolism. For all clinical trials, go to clinical trials search

This list shows clinical trials for Pulmonary embolism

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Pulmonary embolism
Title Recruitment status Location
Non-Interventional Study on Edoxaban Treatment in Routine Clinical Practice in Patients with Venous Thromboembolism in Europe Recruiting United Kingdom
Multicenter, Open-label, Active-controlled, Randomized Study to Evaluate the Efficacy and Safety of an age-and Body Weight-adjusted Rivaroxaban Regimen Compared to Standard of Care in Children With Acute Venous Thromboembolism Recruiting United Kingdom
30-day, Single-arm Study of the Safety, Efficacy and the Pharmacokinetic and Pharmacodynamic Properties of Oral Rivaroxaban in Young Children With Various Manifestations of Venous Thrombosis Recruiting United Kingdom
A Dose Ranging Trial for the Evaluation of the Safety, Tolerability and Efficacy of Odiparcil in the Prevention of Venous Thromboembolism following Total Knee Replacement Surgery. Not Recruiting United Kingdom
A phase 3, randomized, double-blind, double-dummy, parallel-group, multi-center, multi-national study for the evaluation of efficacy and safety of (LMW) heparin/edoxaban versus (LMW) heparin/warfarin in subjects with symptomatic deep-vein thrombosis and/or pulmonary embolism - Evaluation of edoxaban vs. warfarin in subjects with symptomatic venous thromboembolism (VTE) Not Recruiting United Kingdom
A phase III, randomised, multicenter, double-blind, parallel-group, active controlled study to evaluate the efficacy and safety of oral dabigatran etexilate (150 mg bid) compared to warfarin (INR 2.0-3.0) for the secondary prevention of venous thromboembolism. RE-MEDY - RE-MEDY Not Recruiting United Kingdom
Not Recruiting United Kingdom
A multinational, randomized, double blind, placebo-controlled study to evaluate the efficacy and safety of AVE5026 in the prevention of venous thromboembolism (VTE) in cancer patients at high risk for VTE and who are undergoing chemotherapy. - SAVE-ONCO Not Recruiting United Kingdom
A multinational, randomized, double blind, placebo-controlled study to evaluate the efficacy and safety of AVE5026 in the prevention of venous thromboembolism (VTE) in cancer patients at high risk for VTE and who are undergoing chemotherapy. - SAVE-ONCO Not Recruiting United Kingdom
A multinational, randomized, double blind, placebo-controlled study to evaluate the efficacy and safety of AVE5026 in the prevention of venous thromboembolism (VTE) in cancer patients at high risk for VTE and who are undergoing chemotherapy. - SAVE-ONCO Not Recruiting United Kingdom

Page last reviewed: 13/07/2015

Next review due: 30/11/2017